Intensive cholesterol-lowering therapy for recent stroke or mini-stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding an intensive cholesterol-lowering drug (called a PCSK9 inhibitor) to standard care can reduce the risk of another stroke or heart attack in people who recently had a stroke from narrowed brain or neck arteries. It is a high-dose approach designed to rapidly lower cholesterol and may offer extra protection for those with high Lp(a).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 80 years old.
- You had a recent stroke or a high-risk mini-stroke (TIA) with symptoms starting 3 to 7 days ago.
- You have high cholesterol and high levels of another fat in your blood called Lp(a).
- Your stroke is caused by a blocked or narrowed artery in your neck or brain, or you had multiple small strokes from this cause.
- You have not received clot-busting drugs or clot removal for this event, and you have no major bleeding risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a cholesterol-lowering medicine (called a PCSK9 inhibitor) can help people who recently had a stroke caused by a narrowed artery in the brain. The goal is to see if it reduces the risk of another stroke or helps recovery.
This trial tests a smart computer tool that helps doctors manage your cholesterol treatment with Evolocumab (Repatha). If you have had a recent stroke or mini-stroke and are already taking this medicine, the tool may help you reach your LDL (bad cholesterol) goal faster.
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
This study tests whether starting a cholesterol-lowering injection (a PCSK9 inhibitor) early after a heart attack can slow or shrink the buildup of plaque in other heart arteries that are not the one that was stented. If you have two other arteries with mild blockages, this treatment might help prevent future heart problems.
This trial tests whether a cholesterol-lowering drug (called a PCSK9 inhibitor) can help people who had a stroke and a procedure to clear a blocked vessel. It aims to see if the drug reduces the risk of another stroke or improves recovery.
This trial tests whether quickly starting an aggressive cholesterol-lowering treatment after a stroke improves recovery. It is for people who are about to have a procedure to remove a large blood clot from their brain.
Hear when a new Ischemic Stroke or High-risk TIA (ABCD² ≥ 4) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.